BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhattacharjee S, Banerjee M. Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review. SN Compr Clin Med 2020;:1-11. [PMID: 32984764 DOI: 10.1007/s42399-020-00521-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Sloan B. This Month in JAAD Case Reports: March 2021. J Am Acad Dermatol 2021;84:611. [PMID: 33455738 DOI: 10.1016/j.jaad.2021.01.003] [Reference Citation Analysis]
2 Gaignard ME, Lieberherr S, Schoenenberger A, Benz R. Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine. Hemasphere 2021;5:e618. [PMID: 34263143 DOI: 10.1097/HS9.0000000000000618] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Michaelis S, Pichler A, Stelzer I, Tinchon C, Enko D. Concomitant immune thrombocytopenia and bone marrow hemophagocytosis in a patient with SARS-CoV-2. Clin Chem Lab Med 2021;59:e358-61. [PMID: 33721917 DOI: 10.1515/cclm-2021-0169] [Reference Citation Analysis]
4 Turgutkaya A, Bolaman AZ, Yavaşoğlu İ. COVID-19-associated Evans syndrome: A case report and review of the literature. Transfus Apher Sci 2021;:103339. [PMID: 34896007 DOI: 10.1016/j.transci.2021.103339] [Reference Citation Analysis]
5 Dotan A, Shoenfeld Y. Perspectives on vaccine induced thrombotic thrombocytopenia. J Autoimmun 2021;121:102663. [PMID: 34020254 DOI: 10.1016/j.jaut.2021.102663] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Zama D, Pancaldi L, Baccelli F, Guida F, Gottardi F, Dentale N, Esposito F, Masetti R, Viale P, Pession A. Autoimmune hemolytic anemia in children with COVID-19. Pediatr Blood Cancer 2022;69:e29330. [PMID: 34490986 DOI: 10.1002/pbc.29330] [Reference Citation Analysis]
7 Jawed M, Khalid A, Rubin M, Shafiq R, Cemalovic N. Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP. Open Forum Infect Dis 2021;8:ofab343. [PMID: 34307734 DOI: 10.1093/ofid/ofab343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ceglie G, De Ioris MA, Mercadante S, Olivini N, Del Bufalo F, Marchesani S, Cocca F, Monteferrario E, Boccieri E, Pianese J, Palumbo G. Immune thrombocytopenia in a child with COVID-19: Is it the calm after the (cytokine) storm? Pediatr Blood Cancer 2021;:e29326. [PMID: 34490996 DOI: 10.1002/pbc.29326] [Reference Citation Analysis]
9 Moody R, Wilson K, Flanagan KL, Jaworowski A, Plebanski M. Adaptive Immunity and the Risk of Autoreactivity in COVID-19. Int J Mol Sci 2021;22:8965. [PMID: 34445670 DOI: 10.3390/ijms22168965] [Reference Citation Analysis]
10 Kumar R, Paul SS, Meena VP, Tiwari P, Bhatnagar S, Mohan A. Fifty Shades of COVID-19 - Immune Thrombocytopenic Purpura in HIV-TB-COVID Co-Infection. J Family Med Prim Care 2021;10:2703-5. [PMID: 34568158 DOI: 10.4103/jfmpc.jfmpc_1939_20] [Reference Citation Analysis]
11 Badulescu OV, Popescu D, Ciocoiu M, Rezus C. Immune thrombocytopenia, severe hematological consequence in a patient with COVID-19: A case report. Exp Ther Med 2021;22:1043. [PMID: 34373729 DOI: 10.3892/etm.2021.10475] [Reference Citation Analysis]
12 Peramo-Álvarez FP, López-Zúñiga MÁ, López-Ruz MÁ. Medical sequels of COVID-19. Med Clin (Engl Ed) 2021;157:388-94. [PMID: 34632064 DOI: 10.1016/j.medcle.2021.04.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Rampotas A, Watson E, Burton K, Hill QA, Pavord S. A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK. Br J Haematol 2021. [PMID: 34448203 DOI: 10.1111/bjh.17804] [Reference Citation Analysis]
14 Qasim H, Ali E, Yassin MA. Immune thrombocytopenia relapse post covid-19 vaccine in young male patient. IDCases 2021;26:e01344. [PMID: 34804803 DOI: 10.1016/j.idcr.2021.e01344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Mohammad AM, Sgery ASH, Hussein NR. A rare case of absolute thrombocytopaenia in a COVID-19 patient: Case report. Ann Med Surg (Lond) 2021;72:103097. [PMID: 34840780 DOI: 10.1016/j.amsu.2021.103097] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Montanari M, Canonico B, Nordi E, Vandini D, Barocci S, Benedetti S, Carlotti E, Zamai L. Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19? Adv Biol Regul 2021;81:100820. [PMID: 34419773 DOI: 10.1016/j.jbior.2021.100820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wolf ME, Luz B, Niehaus L, Bhogal P, Bäzner H, Henkes H. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after "COVID-19 Vaccine AstraZeneca" Exposure. J Clin Med 2021;10:1599. [PMID: 33918932 DOI: 10.3390/jcm10081599] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 24.0] [Reference Citation Analysis]
18 Khamsi R. Rogue antibodies could be driving severe COVID-19. Nature 2021;590:29-31. [PMID: 33469204 DOI: 10.1038/d41586-021-00149-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 22.0] [Reference Citation Analysis]
19 Bereczki D, Nagy B, Kerényi A, Nagy G, Szarka K, Kristóf K, Szalay B, Vásárhelyi B, Bhattoa HP, Kappelmayer J. EDTA-Induced Pseudothrombocytopenia Up to 9 Months After Initial COVID-19 Infection Associated with Persistent Anti-SARS-CoV-2 IgM/IgG Seropositivity. Lab Med 2021:lmab050. [PMID: 34415328 DOI: 10.1093/labmed/lmab050] [Reference Citation Analysis]
20 Guirguis N, Rehman T, Shams Y, Gordon M, Mekhaiel E, Rozell S, Pandya M. SARS-CoV-2 Infection Inducing Immune Thrombocytopenic Purpura: Case Series. Ochsner J 2021;21:187-9. [PMID: 34239380 DOI: 10.31486/toj.20.0100] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Koch M, Fuld S, Middeke JM, Fantana J, von Bonin S, Beyer-Westendorf J. Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination - A Case Report. TH Open 2021;5:e315-8. [PMID: 34377889 DOI: 10.1055/s-0041-1731774] [Reference Citation Analysis]
22 Fadiran O. An Atypical Case of COVID-19 Induced Pancytopenia, Rhabdomyolysis and Myocarditis. Cureus 2021;13:e12455. [PMID: 33552773 DOI: 10.7759/cureus.12455] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AEL, Garcia-Valtanen P, Al-Delfi Z, Gummow J, Ferguson C, O'Connor S, Reddi BAJ, Hissaria P, Shaw D, Kok-Lim C, Gleadle JM, Beard MR, Barry SC, Grubor-Bauk B, Lynn DJ. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med 2022;20:26. [PMID: 35027067 DOI: 10.1186/s12916-021-02228-6] [Reference Citation Analysis]
24 Gordon SF, Clothier HJ, Morgan H, Buttery JP, Phuong LK, Monagle P, Chunilal S, Wood EM, Tran H, Szer J, Crawford NW; SAEFVIC and VicSIS investigators. Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia. Vaccine 2021;39:7052-7. [PMID: 34756770 DOI: 10.1016/j.vaccine.2021.10.030] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Fueyo-Rodriguez O, Valente-Acosta B, Jimenez-Soto R, Neme-Yunes Y, Inclán-Alarcón SI, Trejo-Gonzalez R, García-Salcido MÁ. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination. BMJ Case Rep 2021;14:e242220. [PMID: 34059544 DOI: 10.1136/bcr-2021-242220] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
26 Serrano C, Español I, Cascales A, Moraleda JM. Frequently Relapsing Post-COVID-19 Immune Thrombocytopenia. SN Compr Clin Med 2021;:1-4. [PMID: 34308259 DOI: 10.1007/s42399-021-01019-7] [Reference Citation Analysis]
27 Taherifard E, Taherifard E, Movahed H, Mousavi MR. Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases. Hematology 2021;26:225-39. [PMID: 33594951 DOI: 10.1080/16078454.2021.1881225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
28 Gaunt ER, Mabbott NA. The clinical correlates of vaccine-induced immune thrombotic thrombocytopenia after immunisation with adenovirus vector-based SARS-CoV-2 vaccines. Immunother Adv 2021;1:ltab019. [PMID: 34557868 DOI: 10.1093/immadv/ltab019] [Reference Citation Analysis]
29 Ayesh H, Beran A, Mhanna M, Hejeebu S. Secondary Immune Thrombocytopenia Associated With Asymptomatic COVID-19 Successfully Managed With Intravenous Immunoglobulin and Glucocorticoids. Cureus 2021;13:e15153. [PMID: 34178488 DOI: 10.7759/cureus.15153] [Reference Citation Analysis]
30 Helms JM, Ansteatt KT, Roberts JC, Kamatam S, Foong KS, Labayog JS, Tarantino MD. Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine. J Blood Med 2021;12:221-4. [PMID: 33854395 DOI: 10.2147/JBM.S307047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
31 Olsen GM, Rinder HM, Tormey CA. De novo acquired hemophilia as an immune dysregulation phenomenon following SARS-CoV-2 infection. Transfusion 2021;61:989-91. [PMID: 33368293 DOI: 10.1111/trf.16254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
32 Kossiva L, Thirios A, Panagouli E, Panos A, Lampidi S, Bacopoulou F, Tsolia M, Tsitsika A. A Case of COVID-19-Related Thrombocytopenia and Leukopenia in an Adolescent with Mild Symptoms. Children (Basel) 2021;8:509. [PMID: 34208610 DOI: 10.3390/children8060509] [Reference Citation Analysis]
33 Hatmal MM, Al-Hatamleh MAI, Olaimat AN, Hatmal M, Alhaj-Qasem DM, Olaimat TM, Mohamud R. Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects. Vaccines (Basel) 2021;9:556. [PMID: 34073382 DOI: 10.3390/vaccines9060556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
34 Dongre A, Jameel PZ, Deshmukh M, Bhandarkar S. Immune thrombocytopenic purpura secondary to SARS-CoV-2 infection in a child with acute lymphoblastic leukaemia: a case report and review of literature. BMJ Case Rep 2021;14:e245869. [PMID: 34740909 DOI: 10.1136/bcr-2021-245869] [Reference Citation Analysis]
35 Santosa D, Sofro MAU, Farida, Nindita N, Pangarsa EA, Setiawan B, Rizky D, Suharti C. A full-term pregnant woman with secondary Evans syndrome caused by severe coronavirus disease 2019: a case report. J Med Case Rep 2021;15:606. [PMID: 34903274 DOI: 10.1186/s13256-021-03205-6] [Reference Citation Analysis]
36 Kim CS, Choi DR, Lee JH. Immune thrombocytopenic purpura worsened by COVID-19. Blood Res 2021;56:347-9. [PMID: 34880143 DOI: 10.5045/br.2021.2021147] [Reference Citation Analysis]
37 Barcellini W, Giannotta JA, Fattizzo B. Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature. Front Immunol 2020;11:609198. [PMID: 33574816 DOI: 10.3389/fimmu.2020.609198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
38 Galestanian A, Suthar KH, Karnath B. Immune Thrombocytopenic Purpura in a Patient With SARS-CoV-2 and Epstein-Barr Virus. Cureus 2021;13:e13615. [PMID: 33816014 DOI: 10.7759/cureus.13615] [Reference Citation Analysis]
39 Gurbel PA, Tantry US, Storey RF. International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests. J Thromb Thrombolysis 2021. [PMID: 34021852 DOI: 10.1007/s11239-021-02465-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Kim G, Choi EJ, Park HS, Lee JH, Lee JH, Lee KH. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. J Korean Med Sci 2021;36:e306. [PMID: 34751013 DOI: 10.3346/jkms.2021.36.e306] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Islam A, Bashir MS, Joyce K, Rashid H, Laher I, Elshazly S. An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations. Molecules 2021;26:5004. [PMID: 34443589 DOI: 10.3390/molecules26165004] [Reference Citation Analysis]
42 Tang X, Zheng F. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci 2021. [PMID: 34671854 DOI: 10.1007/s10072-021-05679-0] [Reference Citation Analysis]
43 Rijkers GT, Weterings N, Obregon-Henao A, Lepolder M, Dutt TS, van Overveld FJ, Henao-Tamayo M. Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines. Vaccines (Basel) 2021;9:848. [PMID: 34451973 DOI: 10.3390/vaccines9080848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Davoodian A, Umeh C, Novatcheva E, Sassi GP, Ahaneku H, Kundu A. Severe Immune Thrombocytopenia Post-COVID-19: A Case Report. Cureus 2021;13:e19544. [PMID: 34934562 DOI: 10.7759/cureus.19544] [Reference Citation Analysis]
45 Putilina MV, Teplova NV, Bairova KI, Petrikeeva AE, Shabalina NI. [The result of prospective randomized study CITADEL - the efficacy and safety of drug cytoflavin in postcovid rehabilitation]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:45-51. [PMID: 34874654 DOI: 10.17116/jnevro202112110145] [Reference Citation Analysis]
46 Marfe G, Perna S, Shukla AK. Effectiveness of COVID-19 vaccines and their challenges (Review). Exp Ther Med 2021;22:1407. [PMID: 34676000 DOI: 10.3892/etm.2021.10843] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine 2021;39:3329-32. [PMID: 34006408 DOI: 10.1016/j.vaccine.2021.04.054] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
48 Bucke D, Alizadeh K, Hallam S. COVID-19 complicated by immune thrombocytopaenic purpura and internal jugular vein thrombosis. BMJ Case Rep 2021;14:e243680. [PMID: 34285032 DOI: 10.1136/bcr-2021-243680] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Bautista-Becerril B, Campi-Caballero R, Sevilla-Fuentes S, Hernández-Regino LM, Hanono A, Flores-Bustamante A, González-Flores J, García-Ávila CA, Aquino-Gálvez A, Castillejos-López M, Juárez-Cisneros A, Camarena A. Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps. Biomolecules 2021;11:694. [PMID: 34066385 DOI: 10.3390/biom11050694] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Jasaraj RB, Shrestha DB, Gaire S, Kassem M. Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female. Cureus 2021;13:e16871. [PMID: 34513446 DOI: 10.7759/cureus.16871] [Reference Citation Analysis]
51 Peramo-Álvarez FP, López-Zúñiga MÁ, López-Ruz MÁ. Medical sequels of COVID-19. Med Clin (Barc) 2021:S0025-7753(21)00289-X. [PMID: 34140166 DOI: 10.1016/j.medcli.2021.04.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Grimes DR. Balancing benefits and potential risks of vaccination: the precautionary principle and the law of unintended consequences. BMJ Evid Based Med 2021:bmjebm-2021-111773. [PMID: 34933928 DOI: 10.1136/bmjebm-2021-111773] [Reference Citation Analysis]
53 Korompoki E, Gavriatopoulou M, Fotiou D, Ntanasis-Stathopoulos I, Dimopoulos MA, Terpos E. Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologist. Am J Hematol 2022;97:119-28. [PMID: 34687462 DOI: 10.1002/ajh.26384] [Reference Citation Analysis]
54 Marcic L, Marcic M, Kojundzic SL, Marcic B, Capkun V, Vukojevic K. Personalized Approach to Patient with MRI Brain Changes after SARS-CoV-2 Infection. J Pers Med 2021;11:442. [PMID: 34063824 DOI: 10.3390/jpm11060442] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Shulman JG, Ford T, Cervantes-Arslanian AM. Neurologic Emergencies during the Coronavirus Disease 2019 Pandemic. Neurol Clin 2021;39:671-87. [PMID: 33896538 DOI: 10.1016/j.ncl.2021.02.007] [Reference Citation Analysis]
56 Simpson CR, Shi T, Vasileiou E, Katikireddi SV, Kerr S, Moore E, McCowan C, Agrawal U, Shah SA, Ritchie LD, Murray J, Pan J, Bradley DT, Stock SJ, Wood R, Chuter A, Beggs J, Stagg HR, Joy M, Tsang RSM, de Lusignan S, Hobbs R, Lyons RA, Torabi F, Bedston S, O'Leary M, Akbari A, McMenamin J, Robertson C, Sheikh A. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nat Med 2021;27:1290-7. [PMID: 34108714 DOI: 10.1038/s41591-021-01408-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
57 Bahadorizadeh L, Emamikhah M, Pour Mohammad A, Gholizadeh Mesgarha M. Simultaneous Occurrence of Cerebral Venous Sinus Thrombosis and Immune Thrombocytopenic Purpura in a Patient with a History of COVID-19 Infection. Neurol Ther 2021. [PMID: 34714517 DOI: 10.1007/s40120-021-00294-9] [Reference Citation Analysis]
58 Yasuda H, Mori Y, Chiba A, Bai J, Murayama G, Matsushita Y, Miyake S, Komatsu N. Resolution of One-Year Persisting COVID-19 Pneumonia and Development of Immune Thrombocytopenia in a Follicular Lymphoma Patient With Preceding Rituximab Maintenance Therapy: A follow-up Report and Literature Review of Cases With Prolonged Infections. Clin Lymphoma Myeloma Leuk 2021:S2152-2650(21)00273-1. [PMID: 34393077 DOI: 10.1016/j.clml.2021.07.004] [Reference Citation Analysis]
59 Behlivani E, Tragiannidis A, Hatzipantelis E, Panagopoulou P. Immune thrombocytopenia secondary to COVID-19 infection:  Report of two cases. Pediatr Blood Cancer 2021;68:e29175. [PMID: 34061445 DOI: 10.1002/pbc.29175] [Reference Citation Analysis]
60 Danieli MG, Piga MA, Paladini A, Longhi E, Mezzanotte C, Moroncini G, Shoenfeld Y. Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease. Scand J Immunol 2021;94:e13101. [PMID: 34940980 DOI: 10.1111/sji.13101] [Reference Citation Analysis]
61 Kenney A, Adhikari A. Immune thrombocytopenia in a 68-year-old woman after COVID-19 vaccination. Clin Case Rep 2021;9:e04689. [PMID: 34466248 DOI: 10.1002/ccr3.4689] [Reference Citation Analysis]
62 Rahman A, Niloofa R, Jayarajah U, De Mel S, Abeysuriya V, Seneviratne SL. Hematological Abnormalities in COVID-19: A Narrative Review. Am J Trop Med Hyg 2021:tpmd201536. [PMID: 33606667 DOI: 10.4269/ajtmh.20-1536] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
63 Delshad M, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Poopak B, Shokouhi S, Bashash D. Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity. Int Immunopharmacol 2021;99:107995. [PMID: 34304001 DOI: 10.1016/j.intimp.2021.107995] [Reference Citation Analysis]
64 Hayashi K, Wada H, Shiraki K, Makino K. Immune Thrombocytopenia and Cerebral Hemorrhaging Associated with COVID-19. Intern Med 2021;60:3513. [PMID: 34471017 DOI: 10.2169/internalmedicine.7541-21] [Reference Citation Analysis]
65 King ER, Towner E. A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination. Am J Case Rep 2021;22:e931478. [PMID: 34285180 DOI: 10.12659/AJCR.931478] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Millington-Burgess SL, Harper MT. A double-edged sword: antibody-mediated procoagulant platelets in COVID-19. Platelets 2021;32:579-81. [PMID: 33890850 DOI: 10.1080/09537104.2021.1912315] [Reference Citation Analysis]
67 Root-Bernstein R. COVID-19 coagulopathies: Human blood proteins mimic SARS-CoV-2 virus, vaccine proteins and bacterial co-infections inducing autoimmunity: Combinations of bacteria and SARS-CoV-2 synergize to induce autoantibodies targeting cardiolipin, cardiolipin-binding proteins, platelet factor 4, prothrombin, and coagulation factors. Bioessays 2021;43:e2100158. [PMID: 34677872 DOI: 10.1002/bies.202100158] [Reference Citation Analysis]
68 Lee EJ, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, Semple JW, Arnold DM, Godeau B, Lambert MP, Bussel JB. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol 2021;96:534-7. [PMID: 33606296 DOI: 10.1002/ajh.26132] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 67.0] [Reference Citation Analysis]
69 Petcu AE, Dumitru IM, Cernat RC, Șerban CI, Hangan A, Ghiță E, Vlad ND, Dumitrașcu M, Câmpeanu AT, Rugină S. Immune thrombocytopenic purpura secondary to COVID-19 - case report. Germs 2021;11:319-23. [PMID: 34422703 DOI: 10.18683/germs.2021.1268] [Reference Citation Analysis]
70 Mingot-Castellano ME, Alcalde-Mellado P, Pascual-Izquierdo C, Perez Rus G, Calo Pérez A, Martinez MP, López-Jaime FJ, Abalo Perez L, Gonzalez-Porras JR, López Fernández F, Caparrós Miranda IS, González-López TJ, Moreno Beltrán ME, Rubio Escuin R, Jimenez Bárcenas R; on behalf GEPTI (Grupo Español de Trombocitopenia Inmune). Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain. Br J Haematol 2021;194:537-41. [PMID: 33991422 DOI: 10.1111/bjh.17506] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Brazel D, Eid T, Harding C. Warm and Cold Autoimmune Hemolytic Anemia in the Setting of COVID-19 Disease. Cureus 2021;13:e18127. [PMID: 34692337 DOI: 10.7759/cureus.18127] [Reference Citation Analysis]
72 Stepman G, Daley I, Bralts D, Patel JB, Frunzi J. A Case of Immune Thrombocytopenia After COVID-19 Infection. Cureus 2021;13:e15843. [PMID: 34322335 DOI: 10.7759/cureus.15843] [Reference Citation Analysis]